Hypomethylation of the RUNX2 Gene Is a New Potential Biomarker of Primary Osteoporosis in Men and Women
International Journal of Molecular Sciences · 03.07.2024 · 25 (13) · 7312
DOI: 10.3390/ijms25137312 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.07.2024. Verfasst von Bulat Yalaev und 3 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology Research Centre, Dmitriya Ulianova Street, 11, 117036 Moscow, Russia. Hauptthemen laut MEDLINE: Core Binding Factor Alpha 1 Subunit, DNA Methylation, Osteoporosis, CpG Islands. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
The search for the molecular markers of osteoporosis (OP), based on the analysis of differential deoxyribonucleic acid (DNA) methylation in bone cells and peripheral blood cells, is promising for developments in the field of the early diagnosis and targeted therapy of the disease. The Runt-related transcription factor 2 (RUNX2) gene is one of the key genes of bone metabolism, which is of interest in the search for epigenetic signatures and aberrations associated with the risk of developing OP. Based on pyrosequencing, the analysis of the RUNX2 methylation profile from a pool of peripheral blood cells in men and women over 50 years of age of Russian ethnicity from the Volga-Ural region of Russia was carried out. The level of DNA methylation in three CpG sites of the RUNX2 gene was assessed and statistically significant hypomethylation was revealed in all three studied CpG sites in men (U = 746.5, p = 0.004; U = 784, p = 0.01; U = 788.5, p = 0.01, respectively) and in one CpG site in women (U = 537, p = 0.03) with primary OP compared with control. In the general sample, associations were preserved for the first CpG site (U = 2561, p = 0.0001766). The results were obtained for the first time and indicate the existence of potentially new epigenetic signatures of RUNX2 in individuals with OP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Endocrinology Research Centre, Dmitriya Ulianova Street, 11, 117036 Moscow, Russia.
- Internal Medicine & Clinical Psychology Department, Bashkir State Medical University, 450008 Ufa, Russia.
- Medical Genetics Department, Bashkir State Medical University, 450008 Ufa, Russia.
ORCID-Profile: Anton Tyurin, Karina Akhiiarova, Rita Khusainova
Förderung
- Russian Science Foundation
Zitieren
APA
Yalaev, B., Tyurin, A., Akhiiarova, K., & Khusainova, R. (2024). Hypomethylation of the RUNX2 Gene Is a New Potential Biomarker of Primary Osteoporosis in Men and Women. International Journal of Molecular Sciences, 25(13), 7312. https://doi.org/10.3390/ijms25137312
Vancouver
Yalaev B, Tyurin A, Akhiiarova K, Khusainova R. Hypomethylation of the RUNX2 Gene Is a New Potential Biomarker of Primary Osteoporosis in Men and Women. International Journal of Molecular Sciences. 2024;25(13):7312. doi:10.3390/ijms25137312
BibTeX
@article{Yalaev2024,
author = {Yalaev, Bulat and Tyurin, Anton and Akhiiarova, Karina and Khusainova, Rita},
title = {Hypomethylation of the RUNX2 Gene Is a New Potential Biomarker of Primary Osteoporosis in Men and Women},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {13},
pages = {7312},
doi = {10.3390/ijms25137312}
}
EUVIMED